| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |